Category
News & Pipeline
FDA moves, compounding rules, shortages and what's next for GLP-1s.
Compounded Semaglutide Fall 2026: Is Supply Still Safe?
Compounded semaglutide and tirzepatide remain legal and available this fall. Here's the Q4 2026 supply outlook, FDA 503B timeline, and what buyers need to know.
Read →
Compounded Semaglutide FDA Update: Q3 2026 Status
Compounded semaglutide is still legal from licensed 503A clinics. Two months after the FDA deadline, here's the Q3 2026 status and next steps.
Read →
Semaglutide Shortage 2026: What Changed for Buyers
The semaglutide shortage 2026 update: the FDA resolved it in early 2025, but compounded GLP-1 remains available through licensed 503A telehealth clinics.
Read →
Semaglutide Ban 2026: Still Legal? FDA Timeline & Risk
The semaglutide ban isn't final — compounded semaglutide is still legal as of July 2026. Realistic FDA timeline, 3 scenarios, and how to keep access.
Read →
Is Compounded Semaglutide Still Legal in 2026?
The FDA is moving to permanently bar large-scale compounded semaglutide. Here's what the 2026 regulatory shift means if you're currently using it.
Read →